Avara is led by a team of experienced, entrepreneurial industry leaders with proven backgrounds in pharmaceutical manufacturing, healthcare, and technical services.

Avara Pharmaceutical Services is an affiliate of the American Industrial Acquisition Corporation (www.aiac.com).

Paul Fioravanti, MBA, MPA, CAGS

Chief Executive Officer

Paul Fioravanti is the CEO of Avara Pharmaceutical Services. Paul is a proven leader with extensive experience in C-level roles, including leading a startup company to the Inc. 500 for four consecutive years. Among his various business transformations, he led the turnaround and sale of the one of the largest NYC metro based wireless infrastructure companies, successfully sold to a $4 billion private equity group, and was instrumental in the turnaround and sale of a $250 million recreational marine vessel manufacturer, the restoration to profitability of a $300 million industrial manufacturer, and managed advisory for the divestiture of a large healthcare specialty practice chain to a publicly held company.

Earlier in his career, Paul worked directly for the Chairman and CEO of a publicly-held regional energy holding company, as well as in privately-held manufacturing and service companies across a variety of industries . He has also spearheaded and advised early stage startups, strategic and financial exits of businesses, successful post-merger integrations and has led LEAN- and 6S- based process redesign in manufacturing.

Paul holds three degrees from The University of Rhode Island (BS, MPA, MBA), an advanced degree from Bryant University (CAGS) and is a graduate of Leadership Rhode Island. He has served as an advisor and board member to a variety of companies, private equity groups, angel funds, and community and civic organizations during his career and has taught MBA- level courses at four different universities.

Andy Glanville

Executive Vice President, Chief Financial Officer

William Pasek

Executive Vice President, Chief Commercial Officer

Bill Pasek has over 25 years of experience in sales leadership roles. He served as Director of Sales, Regional Vice President and most recently as National Business Director for Quintiles, and has managed and led sales teams ranging from 90 to 450 salespeople. He is a consummate leader in the pharmaceutical industry.

Mr. Pasek started his pharmaceutical career with GSK, where he helped build and lead the dermatology division and established GSK as the most admired company in that therapeutic category. During his time at GSK, he launched 11 brands in the dermatology market. In 2002, he joined Sepracor, which later became Sunovion.

He was a founding member of the Sepracor commercial team and was instrumental in deciding the overall size and structure of the Sepracor sales team. During this time, he helped the organization grow from $200M in sales to $1.4B. He played a significant role in the launch strategy and execution of Lunesta – one of the top 10 pharmaceutical launches at the time.

Mr. Pasek has a degree in Business Economics from the University of Southern Connecticut.

Pam Maguire

Vice President, Human Resources

Pam Maguire began her career in Human Resources for a financial retail chain as Director of HR and Marketing. After the divesture of the organization she was recruited by the company’s health insurance broker and spent several years as a licensed health insurance agent serving the benefits needs of small to medium sized employers. She went to work in the Human Resources Department at a pharmaceutical manufacturing facility and has spent the last 18 years in pharmaceutical manufacturing. Pam has extensive experience in human resources, compensation, benefits, workforce development and training. She is responsible for spearheading consistency across the Avara business units in compensation, benefits, workforce best practices and internal communications platforms.

Pam is a graduate of the University of Oklahoma and is PHR and SHRM-CP certified. She is committed to making sure employees are educated in all aspects of their compensation, benefits, and company resources. Her core commitment is to provide a strong foundation to talent, so the manufacturing sector can compete and offer quality products to our customers. She is a member of SHRM and ASIS. Pam is certified to train in various programs including the Speed of Trust and the change management curriculum, Our Iceberg is Melting. She is currently pursuing her masters of HR Management at Villanova University.

Pam resides in Norman, Oklahoma where she has spent years caring for her family, building a career, and contributing to the community. She has been involved in many community support organizations including the United Way Board of Directors, Jr. Achievement, The Maguire Foundation, and The Sooner Human Resources Society Board and the Central Oklahoma Workforce Investment Board (COWIB).

Ronald Small MBA, BS Pharm, ScD (Hon), FAPhA, FASHP, CEC


Ronald Small’s experience is unique as he has held executive positions in healthcare organizations and has served as an Executive Strategic Advisor to c-suite leaders in Hospitals and Health Systems, Group Buying Organizations (GPOs), The Joint Commission, Pharmacy Professional Organizations and the Pharmaceutical Industry.

Career Highlights include:

  • Board of Trustees for American Pharmaceutical Association
  • Vice-President, Quality, Safety and Service Excellence and Chief Pharmacy Officer at Wake Forest University Baptist Health for approximately 37 years.
  • Interim CIO for the Medical Center's Informatics Center and for two years as Chief Procurement Officer.
  • Consultant for 5 years with the Joint Commission Resources and Joint Commission International.
  • Contributed to the professional body of knowledge on such topics as quality leadership and quality improvement, Lean Six Sigma, antimicrobial utilization stewardship, drug cost reduction strategies, the safe adoption of technologies in the medication use process and quality of care improvement strategies.
  • Invited speaker in the US and internationally addressing patient safety, leadership for quality improvement, and issues related to improving IV medication practices.

E. Paul Larrat


Paul Larrat is Dean and Professor at The University of Rhode Island College of Pharmacy. His research and teaching efforts have focused on drug use in special populations, health policy, and health economics issues. He also served as the Founding Coordinating Dean of URI's Academic Health Collaborative from 2015-19 and Executive Secretary of the RI Crime Laboratory Commission.

Earlier in his career, Paul was employed as Executive Vice President of MIM Health Plans [now Bioscript : BIOS] where he was responsible for the developing the operations of this pharmacy benefit management company. He oversaw the growth of the company from $3 million in gross revenues in 1994 to over $300 million in 1997. His responsibilities there included oversight of clinical services, provider network development, manufacturer contracting, disease state management, quality assurance, provider auditing and credentialing. Paul is a past president of several not-for-profit organizations, including the Rhode Island Pharmacists Association, the Rhode Island Pharmacy Foundation and Cornerstone Adult Services. He has been a leader in organizing several more non-profits, including the RI chapter of the Alzheimer's Association and the Mwea Fund, which assists in advancing health and education in a primary school district in Thika, Kenya.

A graduate of The University of Rhode Island with a Bachelor of Science in Pharmacy in 1982, Paul received a Master of Business Administration in 1984 and Master of Science in Pharmacy Administration in 1988. Most recently he was awarded a Ph. D. in epidemiology from Brown University. In 2004, he was named a NASA Fellow and spent several months at Kennedy Space Center assisting in life sciences research projects focusing on volatile organic compound production during extended space travel. In 2010-11, he served as AAAS/AACP Congressional Health Policy Fellow in the United States Senate, engaged in developing health care and aging legislation and policy in the office of Finance Committee Chair Sen. Ron Wyden (OR-D).

Paul has been married to Amey Larrat for over 30 years and has two grown children, Meghan and Eric. He is an avid outdoorsman, spending time mountaineering, white water canoeing and sailing. His favorite climbs have been Mt. Rainier in Washington and Mt. Kilimanjaro in Tanzania, and he has reached his goal of climbing the 48 high points of the continental US with his son, Eric.

Flor D. Rivera Davila

Interim Assistant Vice President Quality Assurance / Regulatory Affairs, North America

Flor D. Rivera Davila has more than 22 years of experience in the pharmaceutical industry in Plant Management and Operations roles along with a strong focus on quality and compliance.

For the past two years, Flor has served as the Director, Quality for Avara's Arecibo site. During that time, she oversaw the site's successful re-start following Hurricanes Irma and Maria, including managing the site's quality actions completion and documentation.

Flor holds a Bachelor of Science in Biology from the University of Puerto Rico, Rio Piedras Campus and holds an MT certification from the Puerto Rico Department of Health and the American Association of Clinical Pathologists.

Luca Varesi

Interim Assistant Vice President Quality Assurance / Regulatory Affairs, Europe

Luca Varesi has more than 25 years of experience in the pharmaceutical industry, initially with roles in research and development and subsequently holding different roles in Quality Assurance, both in a Production Plant and a Corporate environment, with a strong focus on sterile products.

For the past year and a half, Luca has served as the Leader, Quality Assurance for Avara's Liscate, Italy site. During that time, he successfully defined and implemented QA standards and strategies for the site, while maintaining compliance with EU regulations and company policies.

Luca holds a Degree in Pharmacy from Milan University, and is certified as a Qualified Person (QP) according to European legislation, as well as a professional Pharmacist.